CA
Cormorant Asset Management, LP disclosed a 7.8% stake in CRBP
Cormorant Asset Management, LP reported owning 7.8% of Corbus Pharmaceuticals Holdings, Inc. (CRBP) (1,500,000 shares) in a Schedule 13G filed Nov 2, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 2, 2026
- Source
- Schedule 13G